Editorial: Immune modulation in tumor microenvironment: New perspectives for cancer immunotherapy.
作者信息
Deng Zimu, Sun Xuejun, Cao Jian, Xiao Qian
机构信息
Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences (CAS), Shanghai, China.
Xi'an Jiaotong University, Xi'an, China.
出版信息
Front Cell Dev Biol. 2023 Jan 4;10:1103705. doi: 10.3389/fcell.2022.1103705. eCollection 2022.
PMID:36684430
Abstract
摘要
相似文献
[1]
Editorial: Immune modulation in tumor microenvironment: New perspectives for cancer immunotherapy.
Front Cell Dev Biol. 2023-1-4
[2]
[3]
[4]
[5]
[6]
[Advancements in Single-cell RNA Sequencing Technology
in the Study of the Tumor Microenvironment in Lung Cancer].
Zhongguo Fei Ai Za Zhi. 2024-6-20
[7]
[8]
Harnessing Metabolic Reprogramming to Improve Cancer Immunotherapy.
Int J Mol Sci. 2021-9-24
[9]
Chemokine-Directed Tumor Microenvironment Modulation in Cancer Immunotherapy.
Int J Mol Sci. 2021-9-10
[10]
Establishment of immune suppression by cancer cells in the tumor microenvironment.
Proc Jpn Acad Ser B Phys Biol Sci. 2024
引用本文的文献
本文引用的文献
[1]
Cancer evolution: Special focus on the immune aspect of cancer.
Semin Cancer Biol. 2022-11
[3]
[4]
Metabolic barriers to cancer immunotherapy.
Nat Rev Immunol. 2021-12
[5]
mRNA vaccine for cancer immunotherapy.
Mol Cancer. 2021-2-25
[6]
[7]
DKK2 blockage-mediated immunotherapy enhances anti-angiogenic therapy of Kras mutated colorectal cancer.
Biomed Pharmacother. 2020-7
[8]
[9]
Acquired Resistance to Immune Checkpoint Inhibitors.
Cancer Cell. 2020-4-13
[10]
Beyond tumor mutational burden: potential and limitations in using exosomes to predict response to immunotherapy.
Expert Rev Mol Diagn. 2019-11-10
Zotero 插件